A Sensitive and Specific Diagnostic Panel to Distinguish Diffuse Astrocytoma from Astrocytosis: Chromosome 7 Gain with Mutant Isocitrate Dehydrogenase 1 and p53

One of the major challenges of surgical neuropathology is the distinction of diffuse astrocytoma (World Health Organization [WHO] grade II) from astrocytosis. The most commonly used ancillary tool to solve this problem is p53 immunohistochemistry (IHC), but this is neither sensitive nor specific. Is...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Camelo-Piragua, Sandra, Jansen, Michael, Ganguly, Aniruddha, Kim, J. ChulMin, Cosper, Arjola K., Dias-Santagata, Dora, Nutt, Catherine L., Iafrate, A. John, Louis, David N.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2011
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3061457/
https://ncbi.nlm.nih.gov/pubmed/21343879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/NEN.0b013e31820565f9
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller